This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Catherine Ley, MS; Chinh Le, MD; Elyse M. Olshen; Arthur L. Reingold, MD

JAMA. 1994;271(6):460-463.

Abstract
Objective.
—To determine the reason(s) why serologic tests for Lyme disease are performed, who initiates the test requests, and how the test results are used in a clinical setting.

Design.
—Retrospective cohort.

Setting.
—Prepaid health plan in northern California.

Patients.
—Consecutive sample of 117 patients for whom at least one serologic test for Lyme disease was performed during a 3-month period.

Main Outcome Measures.
—Reason for ordering and result of the serologic test, differential diagnoses, and treatment.

Results.
—One of 117 patients had antibodies to Borrelia burgdorferi. Fifty-six percent of test requests were initiated by the physician and 35% by the patient. Of 66 tests ordered by the physician, 20% were performed because of suspected early Lyme disease, 6% as follow-up of a tick bite, 2% to confirm a prior history of Lyme disease, 14% as a workup for arthritis, and 60% as one of a battery of laboratory tests for vague symptoms. Of 41 tests initiated by the patient, 51% were performed because of a history of a tick bite. The reasons for ordering 10 tests were undetermined.

Conclusion.
—Only 19% of all serologic tests for Lyme disease were performed because the physician suspected Lyme disease in the patient. Particularly in light of the low probability of contracting Lyme disease in California, it appears that this serologic test is being overused. Indiscriminate testing increases health care costs and does not appear to affect treatment decisions. Education is needed regarding the limitations of this serologic test.

(JAMA. 1994;271:460-463)

Author Affiliations
From the Epidemiology Program, School of Public Health, University of California, Berkeley (Mss Ley and Olshen and Dr Reingold) and Kaiser Permanente Medical Group, Santa Rosa, Calif (Dr Le).

Footnotes
Reprint requests to Epidemiology Program, School of Public Health, University of California, 140 Warren Hall, Berkeley, CA 94720 (Ms Ley).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Appropriateness of Lyme Disease Serologic Testing
Ramsey et al.
Ann Fam Med 2004;2:341-344.
ABSTRACT | FULL TEXT  

Use of Serum Immune Complexes in a New Test That Accurately Confirms Early Lyme Disease and Active Infection with Borrelia burgdorferi
Brunner and Sigal
J. Clin. Microbiol. 2001;39:3213-3221.
ABSTRACT | FULL TEXT  

Do We Know What Inappropriate Laboratory Utilization Is?: A Systematic Review of Laboratory Clinical Audits
van Walraven and Naylor
JAMA 1998;280:550-558.
ABSTRACT | FULL TEXT  

Tick Bites and Lyme Disease in an Endemic Setting: Problematic Use of Serologic Testing and Prophylactic Antibiotic Therapy
Fix et al.
JAMA 1998;279:206-210.
ABSTRACT | FULL TEXT  

Expert Advice and Patient Expectations: Laboratory Testing and Antibiotics for Lyme Disease
Barbour
JAMA 1998;279:239-240.
FULL TEXT  

Lyme Disease: Shift the Paradigm!
Ellenbogen
Arch Fam Med 1997;6:191-195.
ABSTRACT  

Test for Lyme Disease in a Prepaid Health Plan
Berardi and Seder
JAMA 1994;272:203-203.
ABSTRACT